<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">108784</article-id><article-id pub-id-type="doi">10.26442/00403660.2022.05.201494</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Phenotypes of body composition, physical performance and quality of life in women with rheumatoid arthritis</article-title><trans-title-group xml:lang="ru"><trans-title>Фенотипы состава тела, физическая работоспособность и качество жизни у женщин с ревматоидным артритом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2809-0197</contrib-id><name-alternatives><name xml:lang="en"><surname>Dobrovolskaya</surname><given-names>Olga V.</given-names></name><name xml:lang="ru"><surname>Добровольская</surname><given-names>Ольга Валерьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>канд. мед. наук, науч. сотр. лаб. остеопороза</p></bio><email>olgavdobr@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4739-4302</contrib-id><name-alternatives><name xml:lang="en"><surname>Toroptsova</surname><given-names>Natalia V.</given-names></name><name xml:lang="ru"><surname>Торопцова</surname><given-names>Наталья Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>д-р мед. наук, зав. лаб. остеопороза</p></bio><email>olgavdobr@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7661-3124</contrib-id><name-alternatives><name xml:lang="en"><surname>Feklistov</surname><given-names>Alexey Yu.</given-names></name><name xml:lang="ru"><surname>Феклистов</surname><given-names>Алексей Юрьевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>мл. науч. сотр. лаб. остеопороза</p></bio><email>olgavdobr@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0961-9785</contrib-id><name-alternatives><name xml:lang="en"><surname>Demin</surname><given-names>Nikolay V.</given-names></name><name xml:lang="ru"><surname>Демин</surname><given-names>Николай Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>мл. науч. сотр. лаб. остеопороза</p></bio><email>olgavdobr@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8155-6101</contrib-id><name-alternatives><name xml:lang="en"><surname>Sorokina</surname><given-names>Arina O.</given-names></name><name xml:lang="ru"><surname>Сорокина</surname><given-names>Арина Олеговна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>мл. науч. сотр. лаб. остеопороза</p></bio><email>olgavdobr@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6759-8367</contrib-id><name-alternatives><name xml:lang="en"><surname>Nikitinskaya</surname><given-names>Oksana A.</given-names></name><name xml:lang="ru"><surname>Никитинская</surname><given-names>Оксана Анатольевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>канд. мед. наук, ст. науч. сотр. лаб. остеопороза</p></bio><email>olgavdobr@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Nasonova Research Institute of Rheumatology</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-06-17" publication-format="electronic"><day>17</day><month>06</month><year>2022</year></pub-date><volume>94</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>654</fpage><lpage>660</lpage><history><date date-type="received" iso-8601-date="2022-06-16"><day>16</day><month>06</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-06-16"><day>16</day><month>06</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/108784">https://ter-arkhiv.ru/0040-3660/article/view/108784</self-uri><abstract xml:lang="en"><p><bold>Aim. </bold>To evaluate the frequency of different body composition phenotypes, physical performance (PP) and their relationship with quality of life in women with rheumatoid arthritis (RA).</p> <p><bold>Materials and methods. </bold>The study included 157 women (average age 58.6±8.8 years) with RA. Clinical and laboratory examination, dual-energy X-ray absorptiometry, quality of life assessment according to the questionnaires EQ-5D (European Quality of Life Questionnaire), HADS (Hospital Anxiety and Depression Scale) and RAID (Rheumatoid Arthritis Impact of Disease), determination of muscle strength and the PP of skeletal muscles were carried out.</p> <p><bold>Results. </bold>Osteoporotic, sarcopenic and osteosarcopenic phenotypes of body composition were identified in 27 (17%), 16 (10%) and 16 (10%) patients, respectively; 139 (88.5%) people had low muscle strength, and 96 (61.1%) had reduced PP. Quality of life according to the EQ-5D index and RAID, the severity of depression according to HADS in women with different phenotypes of body composition did not differ. Women with osteosarcopenic phenotype had worse indicators for EQ-5D-VAS (VAS – visual analog scale), and patients with sarcopenic phenotype had more severe anxiety according to the HADS questionnaire compared to those with normal phenotype (<italic>p</italic>=0.014 and <italic>p</italic>=0.027, respectively). The quality of life according to all questionnaires was significantly worse in patients with reduced PP.</p> <p><bold>Conclusion. </bold>Pathological phenotypes of body composition were found in 37% of RA patients. A decrease in muscle strength was revealed in 88.5%, and a low PP – in 61.1% of patients. The relationship between quality of life and body composition has not been established, at the same time quality of life associated with the PP of skeletal muscles.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель. </bold>Оценить частоту различных фенотипов состава тела, физическую работоспособность (ФРС) и их связь с качеством жизни (КЖ) у женщин с ревматоидным артритом (РА).</p> <p><bold>Материалы и методы. </bold>В исследование включены 157 женщин (средний возраст 58,6±8,8 года) с диагнозом РА. Проведены клинико-лабораторное обследование, двуэнергетическая рентгеновская абсорбциометрия, оценка КЖ по опросникам EQ-5D (European Quality of Life Questionnaire), HADS (Hospital Anxiety and Depression Scale) и RAID (Rheumatoid Arthritis Impact of Disease), определение силы мышц и ФРС скелетных мышц.</p> <p><bold>Результаты. </bold>Остеопоротический, саркопенический и остеосаркопенический фенотипы состава тела выявлены у 27 (17%), 16 (10%) и 16 (10%) пациенток соответственно; 139 (88,5%) человек имели низкую мышечную силу, а 96 (61,1%) – сниженную ФРС. КЖ по индексу EQ-5D и RAID, выраженность депрессии по HADS у женщин с различными фенотипами состава тела не различались. Женщины с остеосаркопеническим фенотипом имели худшие показатели по EQ-5D-ВАШ (ВАШ – визуальная аналоговая шкала), а с саркопеническим фенотипом – более выраженную тревогу по анкете HADS по сравнению с лицами с нормальным фенотипом (<italic>р</italic>=0,014 и <italic>р</italic>=0,027 соответственно). КЖ по всем опросникам было значимо хуже у пациенток со сниженной ФРС.</p> <p><bold>Заключение. </bold>Патологические фенотипы состава тела обнаружены у 37% больных РА. Уменьшение мышечной силы выявлено у 88,5%, а низкая ФРС – у 61,1% пациенток. Не установлено взаимосвязи между КЖ и составом тела, в то же время КЖ зависело от ФРС скелетных мышц.</p></trans-abstract><kwd-group xml:lang="en"><kwd>rheumatoid arthritis</kwd><kwd>body composition</kwd><kwd>osteoporosis</kwd><kwd>sarcopenia</kwd><kwd>quality of life</kwd><kwd>physical performance</kwd><kwd>muscle strength</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ревматоидный артрит</kwd><kwd>состав тела</kwd><kwd>остеопороз</kwd><kwd>саркопения</kwd><kwd>качество жизни</kwd><kwd>физическая работоспособность</kwd><kwd>сила мышц</kwd></kwd-group><funding-group><funding-statement xml:lang="en">The study was carried out within the framework of the fundamental scientific topic "Development of an interdisciplinary personalized model of care for patients with autoinflammatory degenerative diseases (osteoarthritis, osteoporosis, sarcopenia, gout, pyrophosphate arthropathy) and multimorbidity (obesity, cardiovascular diseases)", No. 1021051403074-2.</funding-statement><funding-statement xml:lang="ru">Исследование выполнено в рамках фундаментальной научной темы «Разработка междисциплинарной персонализированной модели оказания помощи пациентам с аутовоспалительными дегенеративными заболеваниями (остеоартрит, остеопороз, саркопения, подагра, пирофосфатная артропатия) и мультиморбидностью (ожирение, сердечно-сосудистые заболевания)», регистрационный №1021051403074-2.</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Demontiero O, Boersma D, Suriyaarachchi P, Duque G. Clinical outcomes of impaired muscle and bone interactions. Clin Rev Bone Miner Metab. 2014;12:86-92. DOI:10.1007/s12018-014-9164-7</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Cruz-Jentoft AJ, Bahat G, Bauer JM, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. DOI:10.1093/ageing/afy169</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Beenakker K, Ling C, Meskers C, et al. Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev. 2010;9(4):431-6. DOI:10.1016/j.arr.2010.05.005</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Торопцова Н.В., Добровольская О.В., Ефремова А.О., Никитинская О.А. Диагностическая значимость опросника SARC-F и тестов оценки мышечной силы для выявления саркопении у больных ревматоидным артритом. Научно-практическая ревматология. 2020;58(6):678-82 [Toroptsova NV, Dobrovolskaya OV, Efremova AO, Nikitinskaya OA. Diagnostic value of the SARC-F questionnaire and muscle strength tests for the detection of sarcopenia in patients with rheumatoid arthritis. Rheumatology Science and Practice. 2020;58(6):678-82 (in Russian)]. DOI:10.47360/1995-4484-2020-678-682</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ekblom B, Lövgren O, Alderin M, et al. Physical Performance in Patients with Rheumatoid Arthritis. Scand J Rheumatol. 1974;3(3):121-5. DOI:10.3109/03009747409097136</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Stavropoulos-Kalinoglou A, Metsios G, Koutedakis Y, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis. 2007;66(10):1316-21. DOI:10.1136/ard.2006.060319</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Salaffi F, Carotti M, Gasparini S, et al. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes. 2009;7:25. DOI:10.1186/1477-7525-7-25</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Garip Y, Eser F, Bodur H. Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status. Rheumatol Int. 2011;31(6):769-72. DOI:10.1007/s00296-009-1353-1</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Haugeberg G, Orstavik RE, Uhlig T, et al. Clinical decision rules in rheumatoid arthritis: do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis Register. Ann Rheum Dis. 2002;61(12):1085-9. DOI:10.1136/ard.61.12.1085</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Sarkis KS, Salvador MB, Pinheiro MM, et al. Association between osteoporosis and rheumatoid arthritis in women: a cross-sectional study. Sao Paulo Med J. 2009;127(4):216-22. DOI:10.1590/s1516-31802009000400007</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Forsblad d'Elia H, Larsen A, Waltbrand E, et al. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalized osteoporosis. Ann Rheum Dis. 2003;62(7):617-23. DOI:10.1136/ard.62.7.617</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Lee JH, Sung YK, Choi CB, et al. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2016;17:98. DOI:10.1186/s12891-016-0952-8</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Mochizuki T, Yano K, Ikari K, Okazaki K. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study. Geriatr Gerontol Int. 2019;19(9):907-12. DOI:10.1111/ggi.13747</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Minamino H, Katsushima M, Torii M, et al. Serum vitamin D status inversely associates with a prevalence of severe sarcopenia among female patients with rheumatoid arthritis. Sci Rep. 2021;11(1):20485. DOI:10.1038/s41598-021-99894-6</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Vlietstra L, Stebbings S, Meredith-Jones K, et al. Sarcopenia in osteoarthritis and rheumatoid arthritis: The association with self-reported fatigue, physical function and obesity. PLoS ONE. 2019;14(6):e0217462. DOI:10.1371/journal.pone.0217462</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Barone M, Viggiani MT, Anelli MG, et al. Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors. J Clin Med. 2018;7(12):504. DOI:10.3390/jcm7120504</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Wiegmann S, Armbrecht G, Borucki D, et al. Association between sarcopenia, physical performance and falls in patients with rheumatoid arthritis: a 1-year prospective study. BMC Musculoskelet Disord. 2021;22(1):885. DOI:10.1186/s12891-021-04605-x</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Tekgoz E, Colak S, Ozalp Ates FS, et al. Sarcopenia in rheumatoid arthritis: Is it a common manifestation? Int J Rheum Dis. 2020;23(12):1685-91. DOI:10.1111/1756-185X.13976</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Katchamart W, Narongroeknawin P, Chanapai W, Thaweeratthakul P. Health-related quality of life in patients with rheumatoid arthritis. BMC Rheumatol. 2019;3:34. DOI:10.1186/s41927-019-0080-9</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ji J, Zhang L, Zhang Q, et al. Functional disability associated with disease and quality-of-life parameters in Chinese patients with rheumatoid arthritis. Health Qual Life Outcomes. 2017;15(1):89. DOI:10.1186/s12955-017-0659-z</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Kang SY, Lim J, Park HS. Relationship between low handgrip strength and quality of life in Korean men and women. Qual Life Res. 2018;27(10):2571-80. DOI:10.1007/s11136-018-1920-6</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Sun S, Lee H, Yim HW, et al. The impact of sarcopenia on health-related quality of life in elderly people: Korean National Health and Nutrition Examination Survey. Korean J Intern Med. 2019;34(4):877-84. DOI:10.3904/kjim.2017.182</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Сафонова Ю.А., Зоткин Е.Г., Торопцова Н.В. Качество жизни и синдром усталости у пожилых пациентов с саркопенией. Современная ревматология. 2021;15(6):41-7 [Safonova YuA, Zotkin EG, Toroptsova NV. Quality of life and fatigue in elderly patients with sarcopenia. Modern Rheumatology Journal. 2021;15(6):41-7 (in Russian)]. DOI:10.14412/1996-7012-2021-6-41-47</mixed-citation></ref></ref-list></back></article>
